Profile
Robin G.
Taylor is currently Chief Commercial Officer at Agenus, Inc. since 2023.
Formerly, Dr. Taylor was Chief Commercial Officer at Seagen, Inc. from 2019 to 2020 and Head-Immuno-Oncology Franchise at AstraZeneca PLC from 2018 to 2019.
Education includes an undergraduate degree from the University of British Columbia, a doctorate from the University of Toronto, and an MBA from the University of California, Berkeley.
Robin Taylor active positions
| Companies | Position | Start |
|---|---|---|
| AGENUS INC. | Corporate Officer/Principal | 19/07/2023 |
Former positions of Robin Taylor
| Companies | Position | End |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | 31/01/2020 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 31/03/2019 |
Training of Robin Taylor
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Agenus, Inc.
Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Robin Taylor
















